OCS Awards Pluristem With $3.3M Grant

Israeli biotechnology company Pluristem, which develops various treatments from human placentas, has received approval for a NIS 12 million (approx. $3.3 million) grant from the Office of the Chief Scientist (OCS) within the Israeli Ministry of Economy. Once received, the grant will be used to cover R&D expenses for the period January 2013 to December 2013.